Development of an in-house HPLC method for the analysis of ecstasy-laced beverages
© The Author(s) 2018
Received: 26 September 2017
Accepted: 1 February 2018
Published: 10 February 2018
The Correction to this article has been published in Egyptian Journal of Forensic Sciences 2018 8:21
Pills of ecstasy continue to be the major drug of abuse among nightclub patrons. This stimulant type of substance can be taken orally in many ways, one of which is by drink spiking where the tablet or its powder is deliberately added to some beverage before consumption.
A high performance liquid chromatographic (HPLC) method was developed to quantify three analytes (methamphetamine, 3,4-methylenedioxymethamphetamine and ketamine) extracted from beverages associated with drink spiking. Ribena drink, Lipton tea drink and Pepsi soft drink were employed as the target sample matrices for validation studies.
The HPLC method was found precise (RSD < 3.2%) and accurate (mean recovery between 97 and 107%) regardless of the matrix type used. The linearity curve for each analyte presented a good regression line with a coefficient of determination, R2 > 0.994. The method was sensitive to detect at least 0.004 mg/mL spiked drugs and precise to quantify the lowest limit of analytes at 0.02 mg/mL.
Analysis of beverages which were contrivedly spiked with genuine ecstasy substances substantiated that the method is fit for the intended purpose.
Since the emergence of synthetic drugs, rampant use of ecstasy tablets in nightclubs has become a chronic issue for more than a decade. These tablets generally contain such amphetamine-type stimulants (ATS) as 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine (MA), 3,4-methylenedioxyamphetamine (MDA) and amphetamine as the active ingredients (Cheng et al. 2003). The latter two are however less prevalent in locally seized materials. Ketamine (as an anesthetic and depressant (Kayama 1983)) instead is often employed in ecstasy preparations in lieu of these two compounds. Despite the presence of such a depressant, nearly all ecstasy formulations are able to induce euphoria in the users.
Recently in Malaysia, drug-laced beverages or candies were allegedly reported. Unsolicited addition of drug to a drink (or drink spiking) has been linked to ‘date rape’ (Greene et al. 2007). In the United Kingdom, sedative drugs were identified in deliberately spiked drinks (Scott-Ham and Burton 2005). ATS, opiates and cocaine were also found in urine samples from patients who claimed to have had spiked drinks (Hughes et al. 2007). Among other controlled substances, MDMA and cannabinoids were reported to be some of the illicit drugs used in drink spiking (Greene et al. 2007). Despite the widespread occurrence of drink spiking, there is (to the authors’ knowledge) no published data reporting the common levels of drugs frequently found in beverages laced with ecstasy (especially in Malaysia).
For laboratory testing, ATS compounds embodied in ecstasy tablets are conveniently determined by gas chromatography (GC) and liquid chromatography (LC) (UNODC 2006). Illicit drugs including ATS that had been spiked in vape liquids were analyzed with GC coupled with a mass spectrometer (Chan and Harun 2016). Ultra performance liquid chromatography coupled with tandem mass spectrometry was employed to investigate beverage remains that contained drug residues possibly coming from oral fluids (Øiestad et al. 2014). Established methods pertaining to the analysis of beverages contaminated with illicit drugs are however limited. To cater for this need, an analytical method needs to be in place to quantify illicit drugs present in beverages that are spiked with ecstasy substances. The laboratory findings will eventually help the enforcement body justify whether drink spiking has taken place.
Viewing that MA, MDMA and ketamine are largely found in locally seized ecstasy tablets, so these three active compounds are given emphasis for drink spiking in this study. Since Ribena drink and Lipton tea drink had been submitted by the local authorities for analysis to incriminate date rape, this study thus seeks to develop an in-house high performance liquid chromatographic (HPLC) method for the analysis of the aforesaid beverages (as well as Pepsi soft drink) for MA, MDMA and ketamine present at sub-milligram levels.
Materials and method
Chemicals and reagents
Ketamine hydrochloride was purchased from Toronto Research Chemicals (North York, Canada). Methamphetamine hydrochloride and 3,4-methylenedioxymethamphetamine hydrochloride were the in-house reference materials prepared by the Department of Chemistry Malaysia (Petaling Jaya, Malaysia). Hexylamine was procured from Acros Organics (New Jersey, USA). Methanol, acetonitrile and phosphoric acid were commercially obtained from Merck (Darmstadt, Germany). Ultrapure water was generated from the ultrapure water system at 18.2 MΩcm.
High performance liquid chromatography-photodiode array detector (HPLC-PDA)
Optimized conditions for HPLC
Mobile phase 1 (Bottle B)
Mobile phase 2 (Bottle D)
Phosphoric acid + hexylamine in 1 L water
Mode of mobile phase
Isocratic 7:93 B:D
35 ± 5 °C
Mode of data acquisition
3D data collection
190 to 400 nm
UV max detection for quantification
Total run time
Preparation of standard
A single stock mixture containing MA, MDMA and ketamine, each at 10 mg/mL was prepared in methanol and kept at -20 °C for storage. For daily calibration, 0.4 mL of the stock solution was transferred to a 5 mL volumetric flask. Methanol was added to the mark to obtain a working standard mixture with a final concentration of 0.8 mg/mL for each analyte.
Preparation of ion pairing solution
An ion pairing solution was prepared by pipetting 0.280 mL hexylamine and 5.319 mL phosphoric acid into a glass bottle containing 1 L ultrapure water. The solution was mixed well before use.
Preparation of sample
1 mL of a well-shaken beverage sample was transferred into a 5 mL volumetric flask. Dilution was accomplished by adding methanol to the mark to extract the analyte(s). Then the sample was shaken vigorously for a few seconds. The solution was sonicated for 5 min and filtered through a nylon membrane (≤ 0.45 μm) preinstalled on a syringe filter. The filtrate was then stored in a vial pending analysis.
Three beverage matrices used in this study were Ribena drink, Lipton tea drink and Pepsi soft drink which were purchased from a local store. These samples were employed throughout the course of validation guided by the general guidelines recommended by UNODC (2012).
Six compounds (amphetamine, MA, MDA, MDMA, ketamine and caffeine) can be co-present in any locally seized ecstasy tablets. Therefore, blank matrices of the three chosen beverages as well as their respective spiked samples containing the six co-present compounds were prepared and analyzed. Baselines and resolution of MA, MDMA and ketamine were assessed.
Seven aliquots were employed for precision studies: a working standard at 0.8 mg/mL was prepared; two portions of each beverage respectively containing the target analytes at 0.25 mg/mL and 3 mg/mL were also prepared. Each prepared solution/aliquot was injected 8–10 times consecutively on the same day to study intra-day precision. For inter-day precision, the 0.8 mg/mL standard mixture was injected once over ten different days, while the prepared sample aliquots were each injected trice on six different days to obtain the daily average for the peak areas of each analyte. Percentage relative standard deviation (%RSD) was computed to assess consistency of the analyte’s peak area.
Limits of detection (LOD) and quantification (LOQ)
Three standard mixtures respectively at 0.0008, 0.0015, and 0.0030 mg/mL were prepared in methanol to determine the level at which three signal-to-noise ratio (S/N) with an undistorted ultraviolet (UV) spectrum could be obtained for each analyte. At the same time, the precision achieved by these low level mixtures was also evaluated. Based on the findings derived from the drugs prepared in methanol, it was then decided that each beverage should be spiked with 0.004 and 0.02 mg/mL analytes (equivalent to 0.0008 and 0.004 mg/mL respectively as though after dilution) to test for the LOD and LOQ respectively. For the LOD, the chromatogram was examined to ensure at least 3 S/N was obtained for each peak. For the LOQ, it was confirmed based on the precision of the peak area.
A series of dilutions were prepared in methanol to cover the three analytes at 0.0125, 0.025, 0.05, 0.1, 0.2, 0.4, 0.8 and 1.2 mg/mL in separate mixtures. This series was meant to include 0.0625 to 6 mg/mL analytes in beverage as though before dilution. The series was analyzed for six times on the same day. An area versus concentration curve was plotted for each compound.
Accuracy by recovery
Each beverage was respectively spiked with the target analytes at 0.25 mg/mL (low) and 3 mg/mL (high) prior to sample preparation. Each prepared sample was transferred into two separate vials. Each vial was analyzed in triplicate. The procedure was repeated to obtain data over three days.
Results and discussion
A routinely adopted C18 stationary phase in various column dimensions was tested using buffers prepared from orthophosphoric acid, formate, acetate and phosphate salts at different pH values. Separation of the three target compounds was, in fact, achievable with 30 mM phosphate buffer at pH 7.2 but it was only ideal for analytes at low concentrations. Resolution suffered when a high amount of drug substance was injected, where MA and MDMA peaks coalesced. In contrast, a pentafluorophenyl (PFP) column was able to offer a better base-to-base separation with sufficient resolution between all the target peaks when hexylamine was employed as the major mobile phase in this study.
The use of any available internal standards (e.g. nortriptyline) was impossible as the HPLC conditions seemed insensitive to retain them. Hence, it was decided to utilize the analyte’s peak area alone for accurate quantification. This decision is not unjustifiable since external standard calibration is still plausible in certain situations (UNODC 2012).
Then, inherent interference introduced by the three beverages was checked. Results obtained from blank matrices displayed that the target RTs of MDMA and ketamine respectively at 6.3 and 7.9 min were totally free of matrix interference. But a slightly raised baseline near the RT of MA at 4.6 min was observed from the Ribena matrix, whereas the Lipton and Pepsi matrices showed a readily present caffeine peak at 9.9 min as well as an unknown peak (if zooming in on the chromatogram) eluting before MA. They however did not seem to pose significant threats to the analytical outcome as the target RTs were not significantly interfered.
A good method should display a narrowly spread dataset to imply good stability. Commonly, a minimum of 6 replicates must be employed for precision studies. Since the 0.8 mg/mL mixed standard solution was chosen as a routine calibrator, so more injections (e.g. 10 replicates) were required to confirm its consistency. However for the samples, the replicates (e.g. 8 injections for intra-day or trice on 6 inter- days) were decided based on the possible number of injections required for routine practice.
Results for precision studies
Level of analyte in matrix (mg/mL)
Limits of detection (LOD) and quantification (LOQ)
From the three serial dilutions prepared in methanol, a good RSD (< 4%) was achieved at 0.0030 mg/mL. This again means that stable readings can be obtained if the treated sample has an area response corresponding to that level. Subsequently, it was decided to spike 0.02 mg/mL analytes in each beverage prior to five times dilution to serve as the LOQ. Each prepared aliquot was then injected seven times. All the target peak areas displayed an RSD < 5%, indicating a good level of consistency for quantification.
In narcotic analysis, one-point calibration is widely adopted for routine analysis. In this study, 0.8 mg/mL (equivalent to 4 mg/mL in beverage before dilution) was chosen for this purpose. As a result, this level had to be examined for its suitability by constructing a multiple point calibration curve for the range, 0 to 4 mg/mL through the origin using the linearity data obtained from 0.0125 to 0.8 mg/mL. The curves displayed an R2 value ≥0.999 for all the three compounds. This implies that the one-point calibration curve can ideally approximate the linear calibration pattern when 0.8 mg/mL is chosen as the routine calibration point.
Accuracy by recovery
% Recovery obtained from a three day analysis
107.05 ± 5.94
97.48 ± 3.29%
96.77 ± 3.49%
At the low spiking level, the matrices demonstrated overestimation on the recovered values of MA. This was probably due to the sized up signal contributed by the tiny peak that eluted near MA. Such an enhancement was significantly obscured by a high amount of MA observed at the high spiking level. For MDMA and ketamine, the recovery performance was sufficiently good at both low and high levels although some underestimation was observed. On the whole, the recovery data were satisfactory for the intended purpose.
It must also be noted that good recovery is commonly feasible if the calibration point is set close to the amount to be measured. That said, the 0.8 mg/mL calibration point should not be fixed but adjusted on a case-by-case basis.
Drugs (after 5 times dilution) in mg/mL recovered from beverages in comparison with its amount in solid substances
A simple and straightforward HPLC method was developed for simultaneous determination of MA, MDMA and ketamine present in beverages that had been laced with ecstasy substances. Sample preparation only required each sample to be diluted with methanol (e.g. 1 part sample:4 parts methanol) prior to analysis. The method was found to be precise and accurate. Sample analysis indicated that nearly all of the measured values for the analytes in beverages are slightly underestimated. This however does not compromise justice and thus the method is still fit for the intended purpose.
Availability of data and materials
Data are available but not put in the public domain. It is because we do not wish that irrelevant parties (e.g. defence lawyers) can access and misuse the data.
KWC: preparing the manuscript, performing instrumental analysis and data interpretation. SHR: doing sample preparation and instrumental analysis, contributing ideas. Both authors read and approved the final manuscript.
KW Chan holds a PhD majoring in analytical chemistry with a focus on drug analysis and drug profiling. He was a practicing forensic chemist in narcotic enforcement laboratory for more than 8 years. Currently, he works as a forensic researcher, a position that allows him to actively develop instrumental methods for the testing of illicit substances for narcotic and toxicological cases.
SH Ramli holds a diploma in industrial chemistry. She has had years of laboratory experience in handling narcotic cases. She now works as a research assistant to provide technical assistance in the fields of forensic and water analysis.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Chan KW, Harun H (2016) Identification of illicit drugs in vapes by GC-MS. Australian Journal of Forensic Sciences. https://doi.org/10.1080/00450618.2016.1188985
- Cheng W-C, Poon N-L, Chan M-F (2003) Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong. J Forensic Sci 48:1249–1259View ArticlePubMedGoogle Scholar
- Greene SL, Shiew CM, Streete P, Mustchin SJ, Hugget D, Earl B, Dargan PI (2007) What’s being used to spike your drink? Alleged spiked drink cases in inner city London. Postgrad Med J 83:754–758View ArticlePubMedPubMed CentralGoogle Scholar
- Hughes H, Peters R, Davies G, Griffith K (2007) A study of patients presenting to an emergency department having had a “spiked drink”. Emerg Med J 24:89–91View ArticlePubMedPubMed CentralGoogle Scholar
- Kayama Y (1983) Stimulant and depressant effects of ketamine on neocortical activity in cats. Br J Anaesth 55:655–660View ArticlePubMedGoogle Scholar
- Øiestad EL, Karinen R, Christophersen AS, Vindenes V, Bachs L (2014) Analyses of beverage remains in drug rape cases revealing drug residues – the possibility of contamination from drug concentrated oral fluid or oral cavity contained tablets. J Forensic Sci 59:208–210View ArticlePubMedGoogle Scholar
- Scott-Ham M, Burton FC (2005) Toxicological findings in cases of alleged drug-facilitated sexual assault in the United Kingdom over a 3-year period. Journal of Clinical Forensic Medicine 12:175–186View ArticlePubMedGoogle Scholar
- United Nations Office of Drugs and Crime (2006) Recommended methods for the identification and analysis of amphetamine, methamphetamine and their ring-substituted analogues in seized materials. United Nations, ViennaGoogle Scholar
- United Nations Office on Drugs and Crime (2009) Guidance for validation of analytical methodology and calibration of equipment used for testing of illicit drugs in seized materials and biological specimens. United Nations, ViennaGoogle Scholar
- United Nations Office on Drugs and Crime (2012) Recommended methods for the identification and analysis of cocaine in seized materials. United Nations, ViennaGoogle Scholar